JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kosow, D. P.
Right arrow Articles by Rose, I. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kosow, D. P.
Right arrow Articles by Rose, I. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Ascites Tumor Mitochondrial Hexokinase II

EFFECT OF BINDING ON KINETIC PROPERTIES

David P. Kosow 1 and Irwin A. Rose 1

From the 1 From the Institute for Cancer Research, Philadelphia, Pennsylvania 19111

Initial rate and product inhibition studies of purified hexokinase II of ELD ascites tumor cells were made with the enzyme both free in solution and in complex with mitochondrial particles. In both forms the enzyme exhibits the random sequence of substrate addition that precedes the rate-limiting step. Inhibition patterns with AMP and ADP are similar in the two forms. Anhydroglucitol-6-P, which was a noncompetitive inhibitor with glucose, was competitive with respect to ATP with the soluble form of the enzyme only. When the enzyme was bound to mitochondria, the inhibition persisted at saturating ATP, suggesting that E·ADP is present in the steady state reaction with the bound enzyme form and that a dead-end complex is formed with anhydroglucitol-6-P. That such a condition could occur with the uncomplexed form of the enzyme was shown with a "slow" substrate, inosine triphosphate, in which anhydroglucitol-6-P was noncompetitive with respect to ITP. Detailed comparison indicates that the soluble enzyme is more sensitive to product inhibition at low ATP concentration and less sensitive at high ATP. The apparent affinity of all inhibitors and of ATP is decreased by the interaction of hexokinase II with glucose.

Submitted on March 4, 1968


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Doenst, Q. Han, G. W. Goodwin, P. H. Guthrie, and H. Taegtmeyer
Insulin does not change the intracellular distribution of hexokinase in rat heart
Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E558 - E567.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1968 by the American Society for Biochemistry and Molecular Biology.